Related Experiment Video
Updated: Aug 7, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences
Jason T Blackard1, Nyingi Kemmer, Kenneth E Sherman
1Division of Digestive Diseases, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA. jason.blackard@uc.edu
Insights
Hepatitis C virus (HCV) infects 170 million globally. Research suggests HCV replicates in non-liver cells, but confirming this requires better lab methods to understand disease and treatment.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Chronic hepatitis C virus (HCV) infection affects 170 million people worldwide.
- HCV primarily infects hepatocytes but is linked to numerous extrahepatic diseases.
- Evidence suggests HCV can replicate in extrahepatic tissues, such as peripheral blood mononuclear cells.
Purpose of the Study:
- To investigate the challenges and limitations in confirming HCV replication in extrahepatic sites.
- To highlight the need for improved in vitro systems for studying extrahepatic HCV replication.
- To emphasize the importance of understanding extrahepatic HCV replication for disease pathogenesis and treatment response.
Main Methods:
- Review of current evidence on HCV replication in extrahepatic tissues.
- Discussion of technical challenges in laboratory confirmation of extrahepatic HCV replication.
- Identification of limitations in existing in vitro systems for studying extrahepatic HCV.
Main Results:
- Confirmation of HCV replication in extrahepatic sites faces significant technical hurdles.
- Current in vitro models are insufficient for comprehensive study of extrahepatic HCV replication.
- Extrahepatic HCV replication is implicated in a wide range of non-hepatic complications.
Conclusions:
- Innovative in vitro assays are needed to overcome current limitations.
- Prospective cohort studies combined with advanced assays are essential.
- Further research is crucial for understanding HCV pathogenesis and improving treatment outcomes.
Abstract:
An estimated 170 million persons are infected with the hepatitis C virus (HCV) worldwide. While hepatocytes are the major site of infection, a broad clinical spectrum of extrahepatic complications and diseases are associated with chronic HCV infection, highlighting the involvement of HCV in a variety of non-hepatic pathogenic processes. There is a growing body of evidence to suggest that HCV can replicate efficiently in extrahepatic tissues and cell types, including peripheral blood mononuclear cells. Nonetheless, laboratory confirmation of HCV replication in extrahepatic sites is fraught with technical challenges, and in vitro systems to investigate extrahepatic replication of HCV are severely limited. Thus, future studies of extrahepatic replication should combine innovative in vitro assays with a prospective cohort design to maximize our understanding of this important phenomenon to the pathogenesis and treatment response rates of HCV.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cirrhosis II: Pathophysiology
Inhibitors of Viral Protein Synthesis
Hepatic Drug Excretion: Influencing Factors
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

